Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM 3) |
---|---|
Disease/Condition | Infectious Diseases |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Paul Riska, MD |
Contact Name | Bola Omotosho |
Contact Email | jomotosh@montefiore.org |
Protocol Number | 17-02-07-01 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Infectious Diseases - Colon (Cdiff) |
Adult, Pediatric, Both | Adult |